Mag-al Plus Suspension
NDC Package 55154-9429-5
Package Information
Mag-al Plus (aluminum hydroxide, magnesium hydroxide, and simethicone) suspension is •shake well before using•do not take more than 16 teaspoonfuls in 24 hours or use the maximum dosage for more than 2 weeksadults and children 12 years and oldertake 2 to 4 teaspoonfuls four times a day or as directed by a physicianchildren under 12 yearsconsult a physician. This formulation utilizes a suspension delivery system. Marketed by Cardinal Health 107, Llc, this product is identified by NDC 55154-9429 and is authorized under FDA application M001.
Identification & Billing
- RxCUI: 307746 - aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 20 MG in 5 mL Oral Suspension
- RxCUI: 307746 - aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension
- RxCUI: 307746 - aluminum hydroxide 1200 MG / milk of magnesia 1200 MG / dimethicone 120 MG per 30 ML Oral Suspension
- RxCUI: 307746 - aluminum hydroxide 200 MG / milk of magnesia 200 MG / dimethicone 20 MG per 5 ML Oral Suspension
- RxCUI: 307746 - aluminum hydroxide 400 MG / milk of magnesia 400 MG / dimethicone 40 MG per 10 ML Oral Suspension
Clinical Specifications
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Skin Barrier Activity - [PE] (Physiologic Effect)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 55154 - Cardinal Health 107, Llc
- 55154-9429 - Mag-al Plus
- 55154-9429-5 - 5 CUP, UNIT-DOSE in 1 BAG / 30 mL in 1 CUP, UNIT-DOSE
- 55154-9429 - Mag-al Plus
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55154-9429-5 identifies a specific commercial package of 5 cup, unit-dose in 1 bag / 30 ml in 1 cup, unit-dose of Mag-al Plus, a human over the counter drug labeled by Cardinal Health 107, Llc. This suspension is formulated for oral use and contains aluminum hydroxide; dimethicone, unspecified; magnesium hydroxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cardinal Health 107, Llc on June 07, 2011. The current certification is valid through December 31, 2026.
How is this Cardinal Health 107, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55154942905. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.